These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18590490)

  • 1. [Cytomegalovirus infection in kidney transplant patients: what is the best way to prevent it?].
    Martín-Dávila P; Fortún Abete J
    Nefrologia; 2008; 28(3):253-6. PubMed ID: 18590490
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment and prevention of cytomegalovirus in renal transplant patients: weighing the evidence.
    Hakkert A; Dykeman-Sharpe J
    CANNT J; 2003; 13(3):69-73; quiz 74-5. PubMed ID: 14596201
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis.
    Opelz G; Daniel V; Naujokat C; Fickenscher H; Döhler B
    Lancet Oncol; 2007 Mar; 8(3):212-8. PubMed ID: 17329191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CARI guidelines. CMV disease and kidney transplant: treatment of cytomegalovirus disease in renal transplant recipients.
    Caring for Australians with Renal Impairment (CARI)
    Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S37-40. PubMed ID: 15469554
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylaxis of human cytomegalovirus infection in renal transplant patients with valacyclovir and ganciclovir.
    Zhang P; Wang W; Zhang L; Li SF; Guan LB; Dong LQ; Zhou S; Yu P
    Acta Virol; 2013; 57(3):375-7. PubMed ID: 24020766
    [No Abstract]   [Full Text] [Related]  

  • 6. Case Report of a Rare Presentation of Isolated Cytomegalovirus Hepatitis After Renal Transplantation.
    Soape MP; Rahimi RS; Spak CW; Trotter JF
    Prog Transplant; 2018 Sep; 28(3):296-298. PubMed ID: 29898621
    [No Abstract]   [Full Text] [Related]  

  • 7. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
    J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganciclovir prophylaxis to prevent CMV disease in kidney recipients undergoing anti-lymphocyte globulin treatment for acute rejection.
    Dickenmann MJ; Kabulbayev K; Steiger J; Cathomas G; Reusser P; Tamm M
    Clin Microbiol Infect; 2004 Apr; 10(4):337-9. PubMed ID: 15059125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute cytomegalovirus appendicitis in a renal transplant recipient.
    Posen A; Renckens I; Sagaert X; Kuypers D
    Transpl Infect Dis; 2013 Feb; 15(1):96-7. PubMed ID: 23075276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial cytomegalovirus prophylaxis with ganciclovir: no guarantee for prevention of late serious manifestations of CMV after solid organ transplantation.
    Zandberg M; de Maar EF; Hofker HS; Homan van der Heide JJ; Rosati S; van Son WJ
    Neth J Med; 2005 Nov; 63(10):408-12. PubMed ID: 16301763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is low-dose valganciclovir the same as appropriate-dose valganciclovir?
    Pescovitz MD
    Transplantation; 2007 Jul; 84(1):126; author reply 126-7. PubMed ID: 17627250
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantation.
    Ciancio G; Burke GW; Mattiazzi A; Leibovici Z; Dowdy L; Roth D; Kupin W; Rosen A; Jorge D; Cirocco RE; Miller J
    Clin Transplant; 2004 Aug; 18(4):402-6. PubMed ID: 15233817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Historical comparison of prophylactic ganciclovir for gastrointestinal cytomegalovirus infection in kidney transplant recipients.
    Kim HC; Hwang EA; Park SB; Kim HT; Cho WH
    Transplant Proc; 2012 Apr; 44(3):710-2. PubMed ID: 22483474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and impact of CMV prevention following pediatric organ transplantation.
    Allen UD
    Pediatr Transplant; 2008 Jun; 12(4):389-92. PubMed ID: 18466425
    [No Abstract]   [Full Text] [Related]  

  • 17. A cost too high to bear? Prophylaxis versus preemptive therapy to prevent post-transplantation cytomegalovirus.
    Pescovitz MD
    Kidney Int; 2007 Oct; 72(8):912-3. PubMed ID: 17914417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance immunosuppression and the risk of herpes zoster after kidney transplantation.
    Arasaratnam RJ
    Transpl Infect Dis; 2013 Oct; 15(5):E206. PubMed ID: 24010882
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of consensus guidelines for management of cytomegalovirus infection in renal transplantation.
    Dmitrienko S; Yu A; Balshaw R; Shapiro RJ; Keown PA;
    Kidney Int; 2007 Oct; 72(8):1014-22. PubMed ID: 17700642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to "Maintenance immunosuppression and the risk of herpes zoster after kidney transplantation".
    Kim T; Ko GB; Lee SO
    Transpl Infect Dis; 2013 Oct; 15(5):E207-8. PubMed ID: 24011143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.